SRRK Q1 2022 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+605.0% YoY

Gross Profit

$4M11.5% margin

Operating Income

-$7M-20.9% margin

Net Income

-$8M-24.0% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+719.8%

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$266M

Total Liabilities

$95M

Stockholders' Equity

$171M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$5M	+605.0%
Gross Profit	$4M	-$18M	+121.5%
Operating Income	-$7M	-$27M	+74.5%
Net Income	-$8M	-$28M	+71.3%